The Hellenic Association of Pharmaceutical Companies (SfEE) is a non-profit association representing one of the most innovative, productive and extrovert sectors of the Greek economy. It embodies more than 95% of the pharmaceutical market operating in Greece. The 67 Greek and multinational member – companies, are constantly investing in the development of effective medicines and treatments, in order to ensure people’s right to health and better quality of life. SfEE was founded in 1982 and for 30 years SfEE works to promote positions in support of the common interest of society, the State, and the pharmaceutical companies. Compliance to the Code of ethics - which following recent update incorporated stricter rules -, consists a fundamental principle of all member companies of SfEE. SfEE is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since 1983. It is represented in the EFPIA Committees and as such participates in the procedures of official deliberations among the European Commission, EU authorities, Member States and EFPIA for the shaping of legislation and guidelines governing medicinal products. Through the systematic shaping and upgrading of solid and substantiated positions, SFEE contributes to the enhancement of public health and patients’ access to innovative & generic medicines. Over the years, SfEE has emerged as an equal and reliable partner for the State with its initiatives, proposals and participation in the public dialogue.

 

Please visit www.sfee.gr

 

Association of Greek Clinics

The Hellenic Private Hospitals Association represents the largest private hospitals in the core, and presents the largest private hospitals in the country dedicated to promoting high quality healthcare focused on the patient. It's members are among the largest in Greece and among the biggest contributors to the Greek economy, while, through their services, the members of the Hellenic Private Hospitals Association are actively supporting the needs of the state healthcare system.

 

---

The Greek Union of Private Hospitals is a secondary association-Federation representing the vast majority of Private Clinics operating in Greece, who:

- Offer high quality services in primary and secondary health care
- Constantly invest in new Medical equipment in order to offer new Diagnostic and Treatment methods for the treatment of disease
- Have a strong presence and participation within the Greek Health System, with 15.000 hospital beds and a manpower of 20.000 employees
- Build the future, by envisioning a modern health system, characterized by high efficiency, immediate response, free access to quality services

 

Please visit www.peik.gr

 

---

 

Please visit www.msd.gr

MSD (Merck Sharp & Dohme) is a global healthcare leader and the second largest pharmaceutical company worldwide, working with customers in 140 countries and employing 86.000 people. MSD began to operate in Greece in June 2010 and today employs directly more than 230 people. The company is known as Merck in the United States and Canada, whereas everywhere else, is known as MSD.

From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world, staying focused on our fundamental vision: working for the world to “be well”.

We are inspired by the difference we can make in the lives of people through the innovative medicines, vaccines, and consumer health and animal products we discover and produce. Our products cover a broad range of areas, including heart and respiratory health, infectious diseases and women’s health. MSD is expecting to launch a significant number of new products in Greece including new therapies against Hepatitis C, atherosclerosis, osteoporosis and various neoplasms in the near future.

Today MSD stands out among pharmaceutical companies internationally for the number of medicines it has discovered, since the company’s medicines treat 53% of the 20 most important illnesses globally.

Still, we know there is much more to be done. And we’re doing it, with a long-standing commitment to research and development.

We’re just as committed to expanding access to healthcare and working with others who share our passion to create a healthier world.

Novartis Hellas

We belong to the Novartis Group AG and we are a leading EU company in the global and Greek pharmaceutical industry.

Our success is based on the innovative therapies and medicines we provide to patients, as well as to the quality and expertise of our associates in Novartis Hellas.

In Greece we are focusd on healthcare, offering a diversified portfolio to best meet patients' needs: innovative, patent-protected medicines and consumer health products, which are concentrated in major disease areas such as: Oncology (including Hematology), Cardiovascular and Metabolism (e.g. Hypertension, Diabetes), Multiple Scelerosis, Alzheimer's Disease, Parkinson's disease, Age-Related Macular Degeneration etc.

We employ more than 600 associates.

GENESIS Pharma is a leading Greek biopharmaceutical company. The company has launched and marketed a unique portfolio of innovative biopharmaceutical products in Greece and Cyprus, principally within the specialty therapeutic areas of the Central Nervous System, Haematology, Nephrology, Oncology, Rheumatology and Gastroenterology.

 

Please visit www.genesispharma.gr

 

---

Media sponsor



KERDOS

Please visit www.kerdos.gr

  

---